Quick Answer
NANOVIRICIDES, INC. reported Operating Income Loss of -$9.59 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -12.6% in Operating Income Loss from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), NANOVIRICIDES, INC.'s Operating Income Loss has declined by 45.5%.
- Historical annual values: Fiscal year 2025: -$9.59 million | Fiscal year 2024: -$8.52 million | Fiscal year 2023: -$8.94 million | Fiscal year 2022: -$8.11 million | Fiscal year 2021: -$8.74 million | Fiscal year 2020: -$8.00 million | Fiscal year 2019: -$8.66 million | Fiscal year 2018: -$9.33 million | Fiscal year 2017: -$9.60 million | Fiscal year 2016: -$8.86 million | Fiscal year 2015: -$7.06 million | Fiscal year 2014: -$8.67 million | Fiscal year 2013: -$6.59 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: